» Articles » PMID: 8641114

Gastric Emptying in Diabetes

Overview
Journal Diabet Med
Specialty Endocrinology
Date 1996 Feb 1
PMID 8641114
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric emptying abnormalities are common in diabetic patients but correlate poorly with gastrointestinal symptoms. Poor diabetic control is more likely to lead to gastrointestinal complications of diabetes and the converse is also true. Gastric emptying may be a previously under-recognized contributor to variations in glycaemic control in diabetes. There is evidence for both accelerated and delayed gastric emptying. More rapid gastric emptying would result in higher postprandial glucose levels and, therefore, pharmacological means to delay the rate of gastric emptying may be a new approach to slowing postprandial nutrient absorption and improving diabetic control. Hyperglycaemia reduces the rate of gastric emptying in both Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients. The exact mechanisms responsible for the inhibitory action of hyperglycaemia on gastric emptying are unknown. There is insufficient data on the effect of hypoglycaemia on gastric emptying but one study has reported more rapid gastric emptying.

Citing Articles

Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of : A Real-World Evidence Study.

Jung Y, Kim S, Kim H, Noh S, Park J, Sohn C Gut Liver. 2022; 17(5):711-721.

PMID: 36510776 PMC: 10502490. DOI: 10.5009/gnl220218.


Comparative Efficacy of 14-Day Tegoprazan-Based Triple vs. 10-Day Tegoprazan-Based Concomitant Therapy for Eradication.

Park C, Song M, Jung B, Park J, Jung Y J Pers Med. 2022; 12(11).

PMID: 36422094 PMC: 9695183. DOI: 10.3390/jpm12111918.


Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?.

Azab E, Thabit A, McKee S, Al-Qiraiqiri A Gut Pathog. 2022; 14(1):24.

PMID: 35668511 PMC: 9169378. DOI: 10.1186/s13099-022-00502-3.


Gastroparesis With the Initiation of Liraglutide: A Case Report.

Almustanyir S, Alhabeeb H, AlHusseini N, Al Thow M Cureus. 2021; 12(11):e11735.

PMID: 33403167 PMC: 7773310. DOI: 10.7759/cureus.11735.


Second-line bismuth-containing quadruple therapy for eradication and impact of diabetes.

Kim S, Park M, Park S, Moon W, Kim J, Jung K World J Gastroenterol. 2017; 23(6):1059-1066.

PMID: 28246480 PMC: 5311095. DOI: 10.3748/wjg.v23.i6.1059.